News
Filtrar por
Press release
VaxThera and Codagenix Partner to Advance a Next Generation Yellow Fever Vaccine
VaxThera will further advance Syn17D-YF, the world’s first fully synthetic yellow fever vaccine candidate designed for modern cell-culture manufacturing.
More information
Statement
VaxThera and Hetero announce strategic alliance to expand access to high-cost biologic therapies
Collaboration begins with three monoclonal antibodies and establishes a pathway toward technology transfer and local production in Colombia for Latin America
More information
Noticia
VaxThera and Serum Institute of India Announce a Strategic Collaboration to Strengthen Vaccine Development and Health Security in Colombia
This collaboration represents a historic step forward for Colombia. Together, VaxThera and the Serum Institute of India will launch a collaborative program.
More information
Comunicado
VaxThera Achieves LEED® Gold Certification for Its Manufacturing Facility, Reinforcing Its Commitment to Sustainability
With a design focused on water and energy efficiency, VaxThera has achieved LEED Gold certification, validated by GBCI
More information
Comunicado
VaxThera and Seguros SURA Launch Colombia's Largest Regional Program to Prevent HPV Associated Cancer
In Colombia, cervical cancer is the leading cause of cancer-related death among women between the ages of 20 and 35.
More information
Comunicado
The Ministry of Health and Social Protection of Colombia and the National Health Institute of Colombia sign an agreement with VaxThera to strengthen health sovereignty
The Special Framework Agreement for Scientific and Technological Cooperation signed by Colombia's Ministry of Health, the National Health Institute (INS), and VaxThera represents an innovation model aimed at bringing together efforts to strengthen local capabilities in health sovereignty.
More information
Comunicado
Colombian Company VaxThera Receives Key Patent Grant for Locally Developed COVID-19 Vaccine
VaxThera received a patent for its COVID-19 vaccine from the United States Patent and Trademark Office (USPTO)
More information
Comunicado
Meet the women who contribute to research and science for the development of Colombian vaccines
El 51% de VaxThera está compuesto por mujeres, ocupando roles directivos, de investigación y desarrollo de biológicos en el país.
More information